Back to BCAX
VANGUARD GROUP INC BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
14
Latest value
$3.5M
Q4 2025
Peak value
$32.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $112K |
| Q1 2025 | $13.9M |
| Q1 2025 | $183K |
| Q2 2025 | $80K |
| Q2 2025 | $18.4M |
| Q2 2025 | $143K |
| Q3 2025 | $31.5M |
| Q3 2025 | $3.1M |
| Q3 2025 | $136K |
| Q4 2025 | $195K |
| Q4 2025 | $214K |
| Q4 2025 | $109K |
| Q4 2025 | $32.7M |
| Q4 2025 | $3.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $3.5M | 209.8K | — | — |
| Q4 2025 | $32.7M | 1.95M | — | — |
| Q4 2025 | $109K | 6.5K | — | — |
| Q4 2025 | $214K | 12.7K | — | — |
| Q4 2025 | $195K | 11.6K | — | — |
| Q3 2025 | $136K | 8.6K | — | — |
| Q3 2025 | $3.1M | 197.2K | — | — |
| Q3 2025 | $31.5M | 2.00M | — | — |
| Q2 2025 | $143K | 15.4K | — | — |
| Q2 2025 | $18.4M | 1.98M | — | — |
| Q2 2025 | $80K | 8.6K | — | — |
| Q1 2025 | $183K | 14.0K | — | — |
| Q1 2025 | $13.9M | 1.07M | — | — |
| Q1 2025 | $112K | 8.6K | — | — |
Other funds holding BCAX
$93.9M
$63.1M
$60.8M
$60.8M
$54.4M
$53.4M
$50.1M